Share with your CTO
ASML, the Dutch company that holds a monopoly on extreme ultraviolet lithography machines required to manufacture the world’s most advanced chips, is approaching a $700 billion market cap after shares rose 60 percent this year. Analysts at Barclays, Susquehanna, and Bernstein now set 12-month price targets implying a $1 trillion valuation, roughly $2,600 per share. The bull case rests on continued hyperscaler data center investment and an accelerating memory chip upgrade cycle from older tools to pricier EUV systems.
What this means for your business
The stock conversation is actually a supply chain conversation. ASML sits at the single chokepoint in the entire AI hardware stack: no EUV machine, no leading-edge chip, no GPU cluster for your inference workload. If you’re running or planning large-scale AI infrastructure, the question of whether ASML can ship enough machines, and whether TSMC and Samsung can absorb them, determines your compute roadmap more than your preferred cloud provider’s pricing sheet does.
The upgrade cycle argument is the most underappreciated part of this story. Memory chip makers, SK Hynix chief among them, are retiring older deep ultraviolet tools and buying EUV systems to produce the high-bandwidth memory that Nvidia’s latest GPUs require. That dynamic insulates ASML partially from an AI demand slowdown, because the memory transition has its own momentum. For CTOs building out inference infrastructure, this means HBM supply is tightening from the tooling level up, not just from fab capacity, and that pressure will persist even if hyperscaler capex moderates in 2026.
The real constraint on ASML’s trajectory is geopolitical, not technical. China accounts for a projected 20 percent of ASML’s 2026 revenue, and the proposed U.S. MATCH Act would restrict both sales and servicing of equipment there. A servicing ban is more disruptive than a sales ban, because it degrades fabs already running older ASML tools, which tightens mature-node chip supply globally. CTOs sourcing chips from fabs with China exposure should be pressure-testing that dependency now, before the legislation moves, not after. I’d revise this outlook if the MATCH Act stalls in committee, but the directional risk is clear enough to act on at the vendor diversification level today.
Based on reporting from ASML: The Path to Europe’s First Trillion-Dollar Company Amid AI Chip Demand, ETEnterpriseai, originally published 2026-07-20 06:54:00.
